Q4 2020 Holdings
Filed 2021-02-16 | 57 holdings | $696.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cloudflare Inc(NET) | CL A COM | 18915M107 | $212.0M | 2,763,583 | 30.4% |
| Black Diamond Therapeutics Inc(BDTX) | COM | 09203E105 | $110.6M | 3,449,845 | 15.9% |
| Adaptimmune Therapeutics PLC(ADAPY) | ADR | 00653A107 | $92.1M | 17,082,611 | 13.2% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $88.2M | 13,633,582 | 12.7% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $71.5M | 5,172,683 | 10.3% |
| Annexon Inc(ANNX) | COM | 03589W102 | $62.5M | 2,497,661 | 9.0% |
| Bloom Energy Corp(BE) | COM CL A | 093712107 | $38.2M | 1,333,333 | 5.5% |
| Champions Oncology Inc(CSBR) | COM NEW | 15870P307 | $18.5M | 1,713,720 | 2.7% |
| Desktop Metal Inc | COM CL A | 25058X105 | $488.8K | 28,416,088 | 0.1% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $303.1K | 2,164,704 | 0.0% |
| Eargo Inc | COM | 270087109 | $292.3K | 6,520,948 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $243.4K | 1,590,002 | 0.0% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $178.6K | 2,904,974 | 0.0% |
| Opendoor Technologies Inc(OPEN) | COM | 683712103 | $151.5K | 6,666,548 | 0.0% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $142.9K | 4,912,306 | 0.0% |
| Sprout Social Inc(SPT) | COM CL A | 85209W109 | $140.3K | 3,090,080 | 0.0% |
| Oyster PT Pharma Inc | COM | 69242L106 | $111.5K | 5,925,287 | 0.0% |
| Palo Alto Networks Inc(PANW) | COM | 697435105 | $95.5K | 268,684 | 0.0% |
| Imara Inc | COM | 45249V107 | $88.6K | 4,017,170 | 0.0% |
| Akouos Inc | COM | 00973J101 | $85.2K | 4,298,488 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $84.4K | 5,736,363 | 0.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $73.1K | 4,187,801 | 0.0% |
| Inozyme Pharma Inc | COM | 45790W108 | $50.5K | 2,444,379 | 0.0% |
| Galera Therapeutics Inc(GRTX) | COM | 36338D108 | $44.6K | 4,362,986 | 0.0% |
| Casper Sleep Inc | COM | 147626105 | $38.3K | 6,226,130 | 0.0% |
| Verona Pharma PLC(VRNA) | ADS | 925050106 | $35.8K | 5,108,563 | 0.0% |
| Affimed NV | COM | N01045108 | $35.7K | 6,126,488 | 0.0% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $34.2K | 9,089,041 | 0.0% |
| Genocea Biosciences Inc(GNCAQ) | COM | 372427401 | $25.1K | 10,376,936 | 0.0% |
| Metacrine Inc | COM | 59101E103 | $24.1K | 3,062,977 | 0.0% |
| Upstart Hldgs Inc(UPST) | COM | 91680M107 | $23.4K | 573,184 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM NEW | 12648L601 | $23.0K | 7,140,450 | 0.0% |
| Aveo Pharmaceuticals Inc(0HJQ) | COM | 053588307 | $22.8K | 3,952,958 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $22.5K | 8,533,072 | 0.0% |
| Phasebio Pharmaceuticals Inc | COM | 717224109 | $22.3K | 6,643,704 | 0.0% |
| Geron Corp(GERN) | COM | 374163103 | $21.4K | 13,461,538 | 0.0% |
| Lumos Pharma Inc | COM | 55028X109 | $18.8K | 526,663 | 0.0% |
| Vistagen Therapeutics Inc(VTGNUSD) | COM | 92840H202 | $18.2K | 9,360,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $15.3K | 992,107 | 0.0% |
| Inventiva SA(IVA) | ADS | 46124U107 | $15.1K | 1,041,666 | 0.0% |
| DZS Inc(DZSIQ) | COM | 268211109 | $14.8K | 956,255 | 0.0% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $14.4K | 5,940,796 | 0.0% |
| Strongbridge Biopharma PLC | SHS USD | G85347105 | $10.1K | 4,141,308 | 0.0% |
| Senseonics Holdings Inc(SENS1GBP) | COM | 81727U105 | $10.0K | 11,464,235 | 0.0% |
| Obseva SA | COM | H5861P103 | $9.5K | 4,586,563 | 0.0% |
| Synlogic Inc | COM | 87166L100 | $9.1K | 4,229,410 | 0.0% |
| Regulus Therapeutics Inc | COM NEW | 75915K200 | $8.7K | 6,451,056 | 0.0% |
| Trevena Inc | COM | 89532E109 | $8.2K | 3,811,691 | 0.0% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $8.1K | 2,382,286 | 0.0% |
| Liquidia Technologies Inc(LQDA) | COM | 53635D202 | $7.3K | 2,486,062 | 0.0% |